03866nas a2200265 4500008004100000245008500041210006900126260001500195300001000210490000600220520306100226653001803287653001703305653002603322653001303348653001703361100002503378700002503403700002003428700001903448700002203467700002603489700002003515856006503535 2020 eng d00aPractice and Perception of Pharmacist Intervention Documentation in Saudi Arabia0 aPractice and Perception of Pharmacist Intervention Documentation cMarch 2020 a60-650 v63 a

Objectives: To explore the practice and perceptions of pharmacist intervention documentation in the Kingdom of Saudi Arabia. Methods: This is a 4-month cross-sectional self-administered survey of documentation of pharmacist intervention. The study consisted of two parts: the first part collected demographic information and the second part comprised of a questionnaire with a total of 18 questions. There were domains: pharmacist intervention documentation elements, documentation of clinical impact and cost avoidance, the perception of pharmacist intervention and the barrier of pharmacist intervention documentation. All kinds of pharmacist professionals were included in the survey. We used 5-point Likert response scale system to obtain responses. There were open and close-ended questions. The survey was distributed in an electronic format through the social media (WhatsApp and others) to more than 1000 pharmacist professionals across the Kingdom of Saudi Arabia. The data were obtained through the Survey Monkey system. Results: A total of 128 pharmacists responded to the questionnaire. Of them, 106 (82.81%) were Saudi and 22 (17.19%) were non-Saudi pharmacists. Majority of the responders were in the age group of 25–34 years and 35–44 years (44.53% and 25.00%, respectively). Most of the responders had obtained their Bachelor of Science in Pharmacy degree (40 (31.25%)) and Diploma in Pharmacy (33 (25.78%)) with the majority of pharmacists (112 (87.50%)) not having accreditation for the Board of Pharmaceutical Specialty. Most of the pharmacist-reported intervention items was for brief description of the intervention (94.49 %), date of intervention (93.75%) and pharmacist’s name/identification (93.70%), whereas least reported items was the effect of cost-saving (45.57%), time spent on providing intervention (51.61%) and drug therapeutic classification (65.73%). Most of the documentation of clinical impact and cost avoidance were related to the general pharmacist intervention (75.78%), adverse drug reaction (72.66%) and drug quality reporting (72.22%). Most of the barriers that prevent documentation of pharmacist intervention was lack of time (98 (76.56%)) followed by the statement “there is no system for pharmacist intervention” (43 (33.59%)) and “the analysis of pharmacist intervention does not exist” (41 (32.03%)). Conclusion: Half of the responder’s showed compliance with the practice of pharmacist intervention documentation in the Kingdom of Saudi Arabia. The clinical impact and cost avoidance impact of the pharmacist does not adhere to the documentation with half of the responders. The electronic documentations of pharmacist intervention presented with half of the responders. We recommend to remove the barriers and encourage the pharmacist to carry out documentation. This will improve the system and will improve the clinical and economic benefit of the pharmacist in the Kingdom of Saudi Arabia.

10aDocumentation10aIntervention10aPerception Pharmacist10aPractice10aSaudi Arabia1 aAlomi, Yousef, Ahmed1 aFaraj, Elaf, Mohamad1 aAl-Dosari, Asma1 aAl-Fifi, Asmaa1 aAl-Dossari, Razan1 abin Omar, Haya, Fahad1 aAl-Jaziri, Huda uhttps://www.ptbreports.org/article/2020/6/2/105530ptb2020611